Protagonist Therapeutics

📍 Newark, United States🗓 Founded 2006👥 95 employees💰 Last funded Jun 2017
Biotechnology🌐 protagonist-inc.com
Website LinkedIn
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. Our platform enables us to discover peptides in a de novo fashion with the desired degree of potency, specificity and selectivity, and also engineer oral stability with specific peptidomimetic and chemical modifications.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2006
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Protagonist Therapeutics?
Protagonist Therapeutics has 2 investors on record on gritt.io and 1 late-stage investors.
When did Protagonist Therapeutics last raise funding?
The most recent investment in Protagonist Therapeutics recorded on gritt.io was in June 2017.
When was Protagonist Therapeutics founded?
Protagonist Therapeutics was founded in 2006.
What industry is Protagonist Therapeutics in?
Protagonist Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Protagonist Therapeutics based?
Protagonist Therapeutics is headquartered in Newark, United States.